Tablets & Capsules

TC0417

Issue link: https://www.e-digitaleditions.com/i/807837

Contents of this Issue

Navigation

Page 66 of 67

GMP/GDP certifi ed HEAD OFFICE GERMANY: www.meggle-pharma.de service.pharma@meggle.de Phone +49 8071 73 476 MEGGLE USA: www.meggle-pharma.com customer.service@meggle.com Phone +1 844 4MEGGLE (+1 844 463 4453) MEGGLE's monodispersed combination of alpha- lactose monohydrate, MCC and starch is the world's first high-functionality, triple co-processed excipient. It is specifically designed to ease oral solid dosage form development and manufacture, and is highly suited for direct compression (DC). The benefits speak for themselves. And for CombiLac ® : CombiLac ® . Best of both: compactibility and disintegration. From Meggle. – Excellent compactibility – Excellent flowability – Fast, hardness-independent tablet disintegration for effective API release – Low friability – Overcomes individual ingredient compaction and handling limitations CombiLac ® from MEGGLE: Combining the best of both.

Articles in this issue

Links on this page

Archives of this issue

view archives of Tablets & Capsules - TC0417